High-Dose Intravitreal Topotecan for Refractory or Recurrent Retinoblastoma: Efficacy, Safety and Intraocular Cytokine Profiles.
Listen to this summary
This case series evaluated whether high-dose intravitreal topotecan (100 μg, given every four weeks) could salvage eyes with refractory or recurrent intraocular retinoblastoma. In 15 patients, the treatment achieved a 93% globe salvage rate, complete control of intraocular seeds, and complete regression of intraretinal tumors in 3 of 4 eyes, with no significant decline in electroretinography amplitude and no changes in 27 aqueous humor cytokines. The authors conclude that high-dose intravitreal topotecan is effective and appears safe, though the small, uncontrolled design and short follow-up limit firm conclusions about its use as first-line therapy.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from American journal of ophthalmology
View all →Nov 20, 2026 · American journal of ophthalmology
Association of allergic conjunctivitis severity with meibomian gland abnormalities in children: a cross-sectional study.
Nov 19, 2026 · American journal of ophthalmology
Smoke, Not Smoking, as a Possible Risk Factor Triggering Conversion in Leber's Hereditary Optic Neuropathy: A Retrospective Case Series.
Nov 19, 2026 · American journal of ophthalmology
Historical Redlining and Present-Day Vision Disability in Atlanta, Georgia: The Mediating Role of Neighborhood Deprivation.
Nov 18, 2026 · American journal of ophthalmology
Developing Static Perimetry Thresholds to Assess Visual Field Loss Severity in Patients with Retinitis Pigmentosa.
Nov 17, 2026 · American journal of ophthalmology
Evaluating the Effectiveness of Telemedicine Questionnaire Visits for Post-Operative Strabismus Patients.
Nov 16, 2026 · American journal of ophthalmology
Home and Workplace Secondhand Smoke and Retinal Nerve Fiber Layer Thinning in Never-Smokers: A Nationwide Population-Based Study.
More in Ophthalmology
View all →Nov 19, 2026 · Lancet (London, England)
Seasonal mass vaccination with R21/Matrix-M against malaria in The Gambia and Burkina Faso: an open-label, cluster-randomised, controlled trial.
Nov 19, 2026 · Lancet (London, England)
Reproductive health in women in Britain from 2010 to 2024: findings from repeated, cross-sectional National Surveys of Sexual Attitudes and Lifestyles (Natsal).
Nov 19, 2026 · Lancet (London, England)
Spontaneous coronary artery dissection: implications for women's health, clinical care, and future research.
Nov 19, 2026 · The New England journal of medicine
Assessing Multiple Treatment Regimens for Tuberculosis.
Nov 18, 2026 · The New England journal of medicine
Acute Respiratory Distress Syndrome.
Nov 18, 2026 · Journal of cataract and refractive surgery
Intraocular Pressure Change After Cataract Surgery in Normal-Tension Glaucoma and Nonglaucomatous Eyes: Predictors of Postoperative Response.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


